GERD Management

Difficult to diagnose

Challenging to manage

Esophageal disease patients can have similar symptoms — but their diseases may be different. This means tests aren't always conclusive and treatment isn't always effective:

• Up to 50% of endoscopies for predominant esophageal symptoms are negative.^1,2
• Nearly 1/3 of patients with suspected PPI-resistant non-erosive reflux disease may have primary esophageal motility disorder.³
• 1/3 patients referred with ongoing refractory reflux symptoms while using PPIs doesn’t have GERD.⁴

Simplify the diagnostic journey

Move beyond symptoms with two simple tests

Our solutions help you objectively evaluate the root cause of esophageal motility disorders and GERD.

Two simple tests can transform how you evaluate esophageal motility disorders and GERD:

• Endoflip™ impedance planimetry system measures dimensions and pressure in real-time to evaluate suspected esophageal motility disorders. Impedance planimetry of the upper gastrointestinal tract adds meaningfully to diagnostic evaluation and therapeutic decision-making.⁵
  
• Bravo™ calibration-free reflux testing system measures acid levels in the esophagus for up to 96 hours⁷. Early ambulatory esophageal pH monitoring (in conjunction with endoscopy and manometry) before long-term PPI initiation may help define which patients can avoid PPI use and potentially prevent excess PPI dependence.⁶

Endoflip™ impedance planimetry system learning program

The on-demand eLearning training introduces the Endoflip™ Impedance Planimetry System product technology to diagnose and treat patients suffering of esophageal diseases.

Bravo™ calibration-free reflux testing system e-learning course

This comprehensive course covers various opetational aspects of the Bravo™ calibration-free reflux testing system.